These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33665749)
1. Influence of Dose on Neutrophil-Mediated Delivery of Nanoparticles for Tumor-Targeting Therapy Strategies. Liu M; Li C; NaYan ; Zhao D; Zhang H; Li J; Tang X; Liu X; Deng Y; Song Y AAPS PharmSciTech; 2021 Mar; 22(3):89. PubMed ID: 33665749 [TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity. Luo X; Liu M; Hu L; Qiu Q; Liu X; Li C; Lu M; Liu Y; Zhang T; Zhou S; McClements DJ; Jia X; Deng Y; Song Y Int J Pharm; 2018 Aug; 547(1-2):315-329. PubMed ID: 29886095 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment. Hu L; Luo X; Zhou S; Zhu J; Xiao M; Li C; Zheng H; Qiu Q; Lai C; Liu X; Deng Y; Song Y Pharm Res; 2019 May; 36(7):97. PubMed ID: 31076925 [TBL] [Abstract][Full Text] [Related]
4. [Establishment of an Engineered Bacterial Membrane Biomimetic Nanodrug Delivery System and Its Role in the Treatment of Glioma]. Zhao Y; Li Y; Li J; Ni M; Wang J; Wang X; Cheng L; Niu W; Zhang Y; Wang Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jul; 55(4):861-871. PubMed ID: 39170028 [TBL] [Abstract][Full Text] [Related]
5. Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy. Li C; Qiu Q; Liu M; Liu X; Hu L; Luo X; Lai C; Zhao D; Zhang H; Gao X; Deng Y; Song Y Biomater Sci; 2020 Apr; 8(8):2189-2201. PubMed ID: 32096498 [TBL] [Abstract][Full Text] [Related]
6. Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy. Ding J; Sui D; Liu M; Su Y; Wang Y; Liu M; Luo X; Liu X; Deng Y; Song Y Acta Biomater; 2021 Oct; 134():702-715. PubMed ID: 34339869 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatment. Luo X; Hu L; Zheng H; Liu M; Liu X; Li C; Qiu Q; Zhao Z; Cheng X; Lai C; Su Y; Deng Y; Song Y Drug Deliv; 2018 Nov; 25(1):1200-1212. PubMed ID: 29791241 [TBL] [Abstract][Full Text] [Related]
8. Sialic Acid Conjugate-Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size. Wang S; Yang S; Lai X; Song Y; Hu L; Li C; Shi T; Liu X; Deng Y; Chen G AAPS PharmSciTech; 2021 Jan; 22(1):16. PubMed ID: 33389218 [TBL] [Abstract][Full Text] [Related]
9. A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors. Liu M; Tang X; Ding J; Liu M; Zhao B; Deng Y; Song Y Pharm Res; 2019 Nov; 36(12):176. PubMed ID: 31686241 [TBL] [Abstract][Full Text] [Related]
10. [The development of novel tumor targeting delivery strategy]. Gao HL; Jiang XG Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic/ photothermal therapy enhances neutrophil-mediated ibrutinib tumor delivery for potent tumor immunotherapy: More than one plus one? Qiu Q; Li C; Yan X; Zhang H; Luo X; Gao X; Liu X; Song Y; Deng Y Biomaterials; 2021 Feb; 269():120652. PubMed ID: 33450581 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacodynamics of liposomes modified with different chain length of sialic acid derivatives]. Song YZ; Huang ZJ; Luo X; Wang MJ; Zheng JH; Shi J; Deng YH Yao Xue Xue Bao; 2016 Feb; 51(2):316-24. PubMed ID: 29856587 [TBL] [Abstract][Full Text] [Related]
13. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. Hong M; Zhu S; Jiang Y; Tang G; Pei Y J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485 [TBL] [Abstract][Full Text] [Related]
14. Accumulating nanoparticles by EPR: A route of no return. Ngoune R; Peters A; von Elverfeldt D; Winkler K; Pütz G J Control Release; 2016 Sep; 238():58-70. PubMed ID: 27448444 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Wang J; Sui M; Fan W Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289 [TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy. Qiu Q; Li C; Song Y; Shi T; Luo X; Zhang H; Hu L; Yan X; Zheng H; Liu M; Liu M; Liu M; Yang S; Liu X; Chen G; Deng Y Acta Biomater; 2019 Jul; 92():184-195. PubMed ID: 31108259 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice. Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009 [TBL] [Abstract][Full Text] [Related]
18. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier. Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798 [TBL] [Abstract][Full Text] [Related]
19. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
20. [In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide]. Tu LX; Xu YH; Tang CY; Deng LH; Wu CB Yao Xue Xue Bao; 2012 May; 47(5):646-51. PubMed ID: 22812011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]